Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Liver Failure, Acute × Lamivudine × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hepatitis B 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Lymphoma 1 Liver Failure, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Fibrosis 1 Colorectal Neoplasms 1 Carcinoma, Hepatocellular 1

Interventions

hepatitis B hyperimmune globulin 1 halofantrine 1 adefovir dipivoxil 1 N-monoacetylcystine 1 Lamivudine 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00059267 2024-11-15

Prevention of Recurrent Hepatitis B After Liver Transplantation

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Gastrointestinal

Fibrosis, Hepatitis B, Carcinoma, Hepatocellular, Liver Failure, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡